Abbott Laboratories (NYSE:ABT) received FDA approval to launch the Liberta RC DBS system, the world’s smallest rechargeable deep brain stimulation (DBS) device with remote programming, to treat people ...
Credit: Abbott. Liberta RC DBS is the smallest rechargeable DBS device featuring the NeuroSphere Virtual Clinical, which allows for remote programming capabilities. The Food and Drug Administration ...
Remote DBS programming improved Parkinson symptoms faster and reduced travel burdens, expanding access to specialized care.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results